科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Cell Reports Medicine2026-02-01· Medicine

Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed/refractory CD5+ hematological malignancies

Jiali Cheng, Li Zhu, Jia Wu, Yuhao Zeng, Xia Mao, Shengnan Ding, Jue Wang, Yi Xiao, Xiaoxi Zhou, Wei Mu, Xiaojian Zhu

原始摘要(英文原文)· Original abstract
Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed/refractory CD5+ hematological malignancies — 科研速览 Science Skim